A detailed history of Gamma Investing LLC transactions in Journey Medical Corp stock. As of the latest transaction made, Gamma Investing LLC holds 164 shares of DERM stock, worth $1,197. This represents 0.0% of its overall portfolio holdings.

Number of Shares
164
Holding current value
$1,197
% of portfolio
0.0%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Oct 02, 2025

BUY
$6.9 - $8.54 $1,131 - $1,400
164 New
164 $1.17 Million

Others Institutions Holding DERM

About Journey Medical Corp


  • Ticker DERM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 11,596,500
  • Market Cap $84.7M
  • Description
  • Journey Medical Corporation focuses on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions in the United States. The company's marketed products include Qbrexza, a medicated cloth towelette for the treatment of primary axillary hyperhidrosis; Accutane, an oral isotretinoin drug to treat...
More about DERM
Track This Portfolio

Track Gamma Investing LLC Portfolio

Follow Gamma Investing LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gamma Investing LLC, based on Form 13F filings with the SEC.

News

Stay updated on Gamma Investing LLC with notifications on news.